Replies to post #209933 on Biotech Values

[Bickema]

Whats the point of issuing a PR like this, seems like it would just create a headache for management and IR

[DewDiligence]

INNL acquired by private company for $1.75/sh cash plus contingent payments:

http://finance.yahoo.com/news/gurnet-point-l-p-enters-035800014.html

The buyer is Gurnet Point L.P. The CVR has four components, detailed in the above PR, with a maximum cumulative value of $4.90/sh. Based on the current share price, investors are ascribing about $0.50/sh of NPV to the CVR.

Excluding the CVR, the $1.75 buyout price is a 28% premium to INNL’s share price on 3/15/17, the day before INNL issued a PR saying it was in buyout discussions (#msg-129597307).